
    <div class="mb-4">
        <h3 class="text-lg font-semibold">clinical_data Component</h3>
        <div class="bg-white p-4 rounded-lg border">
            
  <div class="bg-white p-4 rounded shadow-md">
    <h2 class="text-lg font-bold mb-2">Clinical Data</h2>
    <p class="text-gray-600">Our medical product, CardioGuard, has undergone rigorous clinical trials to ensure its safety and efficacy in treating cardiovascular disease.</p>
    <ul class="list-none mb-4">
      <li class="flex items-center mb-2">
        <svg class="h-4 w-4 text-green-600" fill="none" viewBox="0 0 24 24" stroke="currentColor">
          <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 011 18z"></path>
        </svg>
        <span class="text-gray-600">Proven to reduce cardiovascular events by 25% in high-risk patients (Clinical Trial 1)</span>
      </li>
      <li class="flex items-center mb-2">
        <svg class="h-4 w-4 text-green-600" fill="none" viewBox="0 0 24 24" stroke="currentColor">
          <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 011 18z"></path>
        </svg>
        <span class="text-gray-600">Demonstrated significant improvement in patient quality of life, with 80% reporting reduced symptoms (Clinical Trial 2)</span>
      </li>
    </ul>
    <p class="text-gray-600">To learn more about the clinical data supporting CardioGuard, please visit our website or contact us for a comprehensive report.</p>
  </div>

        </div>
        <div class="mt-2">
            <h4 class="font-semibold">MLR Compliance:</h4>
            <pre class="bg-gray-100 p-2 rounded">"After analyzing the provided HTML content, I have identified some potential compliance issues related to Medical Legal Review (MLR) for healthcare communications. Here is a detailed report:\n\n**Compliance Issues:**\n\n1. **Unsubstantiated Claims**: The content makes claims about the product\u0027s efficacy and benefits without providing sufficient evidence or references to support these claims. For example, \"Proven to reduce cardiovascular events by 25% in high-risk patients\" and \"Demonstrated significant improvement in patient quality of life, with 80% reporting reduced symptoms\" are claims that require robust scientific evidence to back them up. It is essential to provide references to credible sources, such as peer-reviewed journals or clinical trial results, to substantiate these claims.\n2. **Lack of Risk Information**: The content only presents the benefits of CardioGuard without discussing potential risks, side effects, or contraindications associated with its use. This imbalance may be perceived as misleading or promotional, which is not compliant with MLR guidelines. It is crucial to provide a fair balance of information, including both benefits and risks, to ensure that patients and healthcare professionals can make informed decisions.\n3. **Unclear Language**: The language used in the content may be unclear or confusing to some audiences. For example, the term \"high-risk patients\" is not defined, and it is unclear what specific population this refers to. Similarly, the phrase \"significant improvement in patient quality of life\" is vague and may require further explanation. It is essential to use clear, concise language that is easy to understand for the intended audience.\n4. **Call to Action**: The content includes a call to action (\"To learn more about the clinical data supporting CardioGuard, please visit our website or contact us for a comprehensive report.\") that may be perceived as promotional. While it is acceptable to provide additional resources or information, it is essential to ensure that the call to action is not overly promotional or encouraging unnecessary use of the product.\n\n**Recommendations:**\n\n1. **Substantiate Claims**: Provide references to credible sources, such as peer-reviewed journals or clinical trial results, to support the claims made about CardioGuard\u0027s efficacy and benefits.\n2. **Include Risk Information**: Add a section or paragraph that discusses potential risks, side effects, or contraindications associated with CardioGuard\u0027s use to ensure a fair balance of information.\n3. **Use Clear Language**: Define technical terms, such as \"high-risk patients,\" and use clear, concise language that is easy to understand for the intended audience.\n4. **Rephrase Call to Action**: Revise the call to action to focus on providing additional educational resources or information, rather than encouraging unnecessary use of the product.\n\n**Conclusion:**\n\nThe provided HTML content has some compliance issues related to unsubstantiated claims, lack of risk information, unclear language, and promotional call to action. To ensure MLR compliance, it is essential to address these issues by providing robust evidence to support claims, including risk information, using clear language, and rephrasing the call to action."</pre>
        </div>
        <button class="mt-2 fractal-bg-blue text-white px-4 py-2 rounded hover:bg-blue-600" onclick="addToRepository('clinical_data', `<html>
  <div class=&quot;bg-white p-4 rounded shadow-md&quot;>
    <h2 class=&quot;text-lg font-bold mb-2&quot;>Clinical Data</h2>
    <p class=&quot;text-gray-600&quot;>Our medical product, CardioGuard, has undergone rigorous clinical trials to ensure its safety and efficacy in treating cardiovascular disease.</p>
    <ul class=&quot;list-none mb-4&quot;>
      <li class=&quot;flex items-center mb-2&quot;>
        <svg class=&quot;h-4 w-4 text-green-600&quot; fill=&quot;none&quot; viewBox=&quot;0 0 24 24&quot; stroke=&quot;currentColor&quot;>
          <path stroke-linecap=&quot;round&quot; stroke-linejoin=&quot;round&quot; stroke-width=&quot;2&quot; d=&quot;M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 011 18z&quot; />
        </svg>
        <span class=&quot;text-gray-600&quot;>Proven to reduce cardiovascular events by 25% in high-risk patients (Clinical Trial 1)</span>
      </li>
      <li class=&quot;flex items-center mb-2&quot;>
        <svg class=&quot;h-4 w-4 text-green-600&quot; fill=&quot;none&quot; viewBox=&quot;0 0 24 24&quot; stroke=&quot;currentColor&quot;>
          <path stroke-linecap=&quot;round&quot; stroke-linejoin=&quot;round&quot; stroke-width=&quot;2&quot; d=&quot;M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 011 18z&quot; />
        </svg>
        <span class=&quot;text-gray-600&quot;>Demonstrated significant improvement in patient quality of life, with 80% reporting reduced symptoms (Clinical Trial 2)</span>
      </li>
    </ul>
    <p class=&quot;text-gray-600&quot;>To learn more about the clinical data supporting CardioGuard, please visit our website or contact us for a comprehensive report.</p>
  </div>
</html>`)">
            Add to Repository
        </button>
    </div>


<script>
    function addToRepository(componentType, content) {
        fetch('/editor/component/add_to_repository', {
            method: 'POST',
            headers: {
                'Content-Type': 'application/x-www-form-urlencoded',
            },
            body: new URLSearchParams({
                'component_type': componentType,
                'content': content
            })
        })
        .then(response => response.json())
        .then(data => {
            if (data.success) {
                alert('Component added to repository successfully!');
                window.parent.postMessage({ type: 'addComponent', componentType: componentType, html: content }, '*');
            } else {
                alert('Failed to add component to repository.');
            }
        })
        .catch(error => {
            console.error('Error:', error);
            alert('An error occurred while adding the component');
        });
    }
</script>